AMBR.US
Amber does finance

Amber International Holding Ltd. (AMBR.US) has become the first Asia-based public company to offer its stock on-chain, trading as AMBRx on the solana blockchain, CEO Wayne Huo confirmed on Tuesday during a live webinar hosted on Futubull by Futu.

Investors can access tokenized stocks like AMBRx alongside industry giants such as Apple, Tesla and Nvidia as part of the the xStocks Alliance, developed by Kraken and Swiss-based Backed, which offers round-the-clock on-chain access to U.S. equities and ETFs.

This new initiative from Amber comes not long after it raised $25.5 million through a private placement with participation from well-known investors including Mile Green, led by Thai conglomerate CP Group’s Chatchaval Jiaravanon, and U.S. blockchain venture capital firm Pantera Capital. The company intends to use the funds to support its strategic investments in cryptocurrencies with high potential such as bitcoin, ethereum and solana, as part of the development of its $100 million crypto ecosystem reserve.   

As a Singapore-based institutional crypto services provider, Amber has also been aggressively striking partnerships with other crypto industry players to broaden its influence in the sector and expand its service offerings.

By Teri Yu

The Bamboo Works offers a wide-ranging mix of coverage on U.S.- and Hong Kong-listed Chinese companies, including some sponsored content. For additional queries, including questions on individual articles, please contact us by clicking here

To subscribe to Bamboo Works free weekly newsletter, click here

Recent Articles

robotaxi commercialization faces hidden barriers

China’s robotaxi commercialization faces hidden barriers

Key hurdles have shifted from purely technological breakthroughs to feasible business models and implementation of policy and regulatory frameworks    By Lead Leo Research Institute In 2025, China’s robotaxi industry…
Illustration of a cosmetic surgeon

Private healthcare’s unclear road, and a surging cosmetic surgeon

Private clinic operators for medical treatments like eye and dental care are facing a difficult path as Chinese consumers rein in their spending. What's ahead for this group? And cosmetic surgery services provider So-Young's shares have soared in recent weeks as investors embrace its shifting business model. Why are they suddenly so confident?